Porton Biopharma expands cancer drug manufacturing capacity
February 2, 2016Manufacturing and Production, Research and Development Erwinase
UK Life Sciences Minister George Freeman yesterday opened a new multi-million pound pharmaceutical manufacturing facility at Wiltshire-based Porton Biopharma Limited …
Sun Pharma takes on Novartis in the US with generic Glivec
February 2, 2016Manufacturing and Production, Research and Development, Sales and Marketing Gleevec, Novartis, Sun Pharma
Mumbai-based drug manufacturer Sun Pharma has launched a generic version of Glivec, for the same indications for which the former …
Sanofi Pasteur launches Zika vaccine R&D
February 2, 2016Manufacturing and Production, Research and Development Sanofi Pasteur, Vaccine, Zika virus
Sanofi Pasteur, the vaccines division of French pharma giant Sanofi, says it has launched a vaccine research and development project …
Europe approves BMS hep C drug for HIV and liver transplant patients
February 1, 2016Research and Development, Sales and Marketing Bristol-Myers Squibb, daclatasvir, daklinza
The European Commission has approved the expanded use of Bristol Myers-Squibb’s hepatitis C drug Daklinza (daclatasvir), to include liver transplant …
AbbVie posts strong Q4 results
February 1, 2016Sales and Marketing AbbVie, Humira, Viekira Pak
AbbVie managed to meet or beat analysts’ expectations in its Q4 financial results report, with extremely strong Humira sales contributing …
PwC appoints Issy Corbett as healthcare M&A partner
February 1, 2016Sales and Marketing pwC
PwC has appointed Issy Corbett as a partner to lead its healthcare M&A team.Corbett joins PwC from Rothschild, where he …
Contigency plans in place while Smith & Nephew boss has cancer treatment
February 1, 2016Manufacturing and Production Olivier Bohuon, Smith & Nephew, medical devices
Medical technology firm Smith & Nephew has announced that chief executive Olivier Bohuon has been diagnosed with a ‘highly treatable …
Merck launches health tech start-up program in Africa
February 1, 2016Manufacturing and Production, Medical Communications, Research and Development
Merck has begun its equity-free accelerator program for digital health start-ups in Nairobi, Kenya- a three-month venture offering $15,000 equity-free …
Ministers reject bid to revive Off Patent Drugs Bill
February 1, 2016Research and Development, Sales and Marketing Access to Medical Treatments (Innovation) Bill, Off Patent Drugs Bill, Off-Patent Drugs Bill, george freeman, parliament, repurposing drugs
Ministers have rejected amendments to a proposed Parliamentary Bill that sought to reintroduce elements of the Off Patent Drugs Bill, …
Actelion’s Uptravi and rare bleeding disorder drug get positive EMA decisions
February 1, 2016Sales and Marketing CHMP, EMA, Uptravi, pulmonary arterial hypertension, selexipag
The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the EMA, has issued positive opinions on …
EMA fast-tracks BMS multiple myeloma drug
February 1, 2016Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, EMA, Empliciti, myeloma
The EMA has recommended granting a marketing authorisation for Bristol Myers-Squibb and AbbVie’s immunotherapy Empliciti for the treatment of multiple myeloma. The …
Gilead Sciences names John Milligan new CEO
January 29, 2016Medical Communications, Sales and Marketing Gilead Sciences, John Martin, John Milligan
Gilead Sciences has announced that chairman and chief executive John Martin is to step down after 20 years at the …
Allergan’s depression drug awarded FDA Breakthrough Therapy status
January 29, 2016Research and Development, Sales and Marketing Allergan, depression, rapastinel
While still adjusting to life as part of Pfizer, Allergan has received some good news in the form of the …
Pharma: How to make mergers work
January 29, 2016Sales and Marketing mergers and acquisitions
Pharma is no stranger to bursts of M&A activity.
Regulation of drug promotion ‘should be toughened up’, study finds
January 29, 2016Medical Communications ABPI Code, Department of Justice, PMCPA, Prescription Medicines Code of Practice Authority, Sunshine Act, marketing, off label, off-label, promotion
The voluntary code of conduct system that regulates the pharma industry’s promotion of off-label prescribing has a ‘limited capacity’ to …
MSD gets FDA approval for hepatitis C drug Zepatier
January 29, 2016Medical Communications, Sales and Marketing FDA, MSD, Zepatier, hepatitis C
The competitive hepatitis C market is to get another contender, with FDA approving MSD’s new combo treatment Zepatier (elbasvir and …
FDA plans greater diversity in clinical trials
January 29, 2016Medical Communications, Research and Development FDA, Robert Califf, clinical trial, patient recruitment
The FDA is to focus on increasing patient diversity in clinical trials in 2016, to “ensure that research participants are …
Sanofi expands Iranian presence with memorandum agreement
January 29, 2016Manufacturing and Production, Medical Communications Iran, Sanofi, Serge Weinberg
Sanofi has become the latest pharmaceutical company to expand its presence in post-sanctions Iran, signing a memorandum of co-operation with …
Aslan Pharmaceuticals appoints eminent cancer researcher to chair scientific advisory board
January 28, 2016Research and Development Aslan, Professor Sir David Lane
Aslan Pharmaceuticals has appointed four global cancer experts to its new scientific advisory board.The Board will be chaired by the …
New HR head as Roche makes corporate executive committee changes
January 28, 2016Medical Communications Roche
The Board of Directors has appointed Cristina Wilbur to succeed Silvia Ayyoubi as head of group human resources and member …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
